Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease

A leading expert provides an overview of the cardiorenal benefits of finerenone in patients with type 2 diabetes and chronic kidney disease.
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Format: Microsoft PowerPoint (.ppt)
File Size: 2.54 MB
Released: July 7, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Related Content

Download this resource to assist with person-centered conversations regarding weight management and type 2 diabetes.

Released: December 9, 2022

Leading experts answer questions related to managing genetic obesity disorders following a live presentation, from Clinical Care Options (CCO)

Stephanie Sisley, MD Fatima Cody Stanford, MD, MPH, MPA, MBA Released: December 7, 2022

Experts review therapeutic interventions for NAFLD/NASH, from Clinical Care Options (CCO)

Manal F. Abdelmalek, MD, MPH
Program Director
Rohit Loomba, MD, MHSc Brent Tetri, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Physician Assistants: 1.5 AAPA Category 1 CME Credits Released: December 7, 2022 Expired: December 6, 2023

Experts provide a review of genetic causes of obesity, including the appropriate use of setmelanotide for treatment of genetic obesity disorders, from Clinical Care Options (CCO)

Stephanie Sisley, MD Fatima Cody Stanford, MD, MPH, MPA, MBA Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Physician Assistants: 1.0 AAPA Category 1 CME Credit Released: December 5, 2022 Expired: December 4, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings